Abstract
The study aims to determine the prevalence of Chronic Kidney Disease (CKD) and its risk factors in patients with Metabolic Syndrome in a tertiary care center in India. It was a hospital-based prospective observational study where NCEP ATP III CRITERIA was used to diagnose patients with Metabolic Syndrome, and CKD was defined according to KDIGO Guidelines. Out of 172 patients with Metabolic Syndrome, CKD was seen in 52 patients, of which 29 were males and 23 were females, so the prevalence of CKD in Metabolic Syndrome patients was about 30.23%. (52/172) P Value = 0.0000204. In our study, the prevalence of hyperglycemia in CKD patients with Metabolic Syndrome was 24.41% (42/172) P Value = .0011. The prevalence of obesity was 19.18% (33/172) P Value = .00844. The prevalence of hypertension was 28.48% (49/172) P Value = 2.72. The prevalence of hypertriglyceridemia was 26.12% (45\172) P Value = 0.000002086. The prevalence of hyperglycemia, obesity, and hypertriglyceridemia was significantly high in males. The prevalence of CKD in Metabolic Syndrome is 30.23% which is quite high, and since the prevalence of CKD is rising in India, we need more studies to look into this aspect of Metabolic Syndrome.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
